| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.28 | 0.4 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.4 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.056 | 0.4 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.34 | 0.4 |